Presenters: Julia Kiehlbauch, Ph.D., D(ABMM) & Zuwen Qiu-Shultz, MPH, CPH
Online CME Credit
Fee: $0.00
Provides 1.00 hour of CE/CME credit (Presented on August 10, 2022; Reviewed August 22, 2022; Expires August 22, 2024)
Presenters: Julia Kiehlbauch, Ph.D., D(ABMM) & Zuwen Qiu-Shultz, MPH, CPH
Online CME Credit
Fee: $0.00
Provides 1.00 hour of CE/CME credit (Presented on August 10, 2022; Reviewed August 22, 2022; Expires August 22, 2024)
Part one of this presentation discusses the organisms now commonly associated with antimicrobial resistance. The presentation reviews both new organisms and mechanisms of resistance. It reviews the methodology involved with the detection of antimicrobial resistance and explains some of the acronyms associated with antimicrobial resistance. Lastly, the presentation discusses the impact that antimicrobial resistance may have on patient care and infection control.
Part two of this presentation addresses what antibiogram is, why we need antibiogram, and how antibiogram is created.
This session topic is part of a six-part series presented by the Nevada Antimicrobial Stewardship Program focused on the core elements of antimicrobial stewardship. To view all session topics in this series, please click on Nevada Antimicrobial Stewardship Program Series.
Following participation in this course, participants should be able to:
CE/CME Certificate - Cost is $0.00
Instructions for receiving CME/CE credit:
For questions concerning the online evaluation or your certificate, please contact our office at (775) 784-4791 or email us at cme@med.unr.edu.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nevada, Reno School of Medicine and the Division of Child and Family Services. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians.
The University of Nevada, Reno School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Nevada, Reno School of Medicine approves this program for 1.00 hours of nursing continuing education credit.
As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of an accredited activity disclose all financial relationships within the prior 24 months with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All relevant financial relationships have been mitigated. Following are those disclosures.
All other presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that they do not have financial relationships with ineligible companies related to the content of this activity.
Infection Control: P. Savard and T.M. Perl. Clin Microbiol Infect 2014;20:854-861
Epidemiology, treatment, & control: R.A. Bonomo, E.M. Burd, J. Conly, B.M. Limbago, L. Poirel, J.A. Segre, and L.F. Westblake. Clin Infect Dis 2018:66:1290-1297
Screening for CP-CRE: S.S. Richter and D. Marchaim. Virulence 2017;8:417-416
https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf
https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf
Biochemistry 54:588-597
Clinical Infectious Disease 2018; 66:1290-1297
Clin Microbiol Infect 2014; 20: 854–861
J Clin Microbiol 55:2321–2333
CLSI M100-ED28:2018 Performance Standards for Antimicrobial Susceptibility Testing, 28th Edition
McNamara LA, Potts C, Blain AE, et al. Detection of Ciprofloxacin-Resistant, β-Lactamase–Producing Neisseria meningitidis Serogroup Y Isolates — United States, 2019–2020. MMWR Morb Mortal Wkly Rep 2020;69:735–739. DOI: http://dx.doi.org/10.15585/mmwr.mm6924a2
Virulence 8:460-469/Clin Microbiol Infect 2014; 20: 821–830
CDC. About Antimicrobial Resistance. 2021; https://www.cdc.gov/drugresistance/about.html. Accessed 8/01/2022.
The Joint Commission. Approved: New Antimicrobial Stewardship Standard. 2016; https://www.jointcommission.org/-/media/enterprise/tjc/imported-resource-assets/documents/new_antimicrobial_stewardship_standardpdf.pdf?db=web&hash=69307456CCE435B134854392C7FA7D76&hash=69307456CCE435B134854392C7FA7D76. Accessed 8/1/2022
CLSI M100-ED32:2022 Performance Standards for Antimicrobial Susceptibility Testing, 32nd Edition. 2022; http://em100.edaptivedocs.net/GetDoc.aspx?doc=CLSI M100 ED32:2022&scope=user. Accessed 8/1/2022.
Southern Nevada Health District. Clark County Antibiogram. 2020; https://www.southernnevadahealthdistrict.org/clark-county-antibiogram/#/. Accessed 8/1/2022.